EquityFlow › Companies › StemSight

StemSight

Biotech · Tampere, FI

Developing off-the-shelf stem-cell therapy to cure corneal blindness.

Funding history

DateRoundAmount
Sep 2021Seed
StemSight, a Finnish stem-cell corneal-blindness biotech, announced a EUR 500k seed round.
$570K

Similar companies in Biotech

ImperagenHaga BiosciencePixelgen TechnologiesGallantChai DiscoverySNIPR BiomeCellbox LabsScope BiosciencesGenLuminaActitheraNUCLIDIUMAnocca
Explore funding flow on EquityFlow →